natgillin/translations-raw huggingface dataset:
Hands must remain behind the needle at all times during use and disposal.
Roke morajo ves čas – med uporabo in odlaganjem – ostati za iglo.
Hands should be washed after handling capsules.
Po uporabi kapsul si je treba umiti roke.
Hands should be washed after handling the tablets.
Po rokovanju s tabletami si je treba umiti roke.
Hands should be washed carefully before and after application of cream.
Roke je potrebno skrbno umiti pred nanašanjem in po nanašanju kreme.
Hands should be washed thoroughly before applying REGRANEX.
Pred nanašanjem zdravila REGRANEX si temeljito umijte roke.
HAQ = Health Assessment Questionnaire; greater values indicate less disability.
večje vrednosti pomenijo večjo okvaro sklepov vprašalnik za oceno zdravstvenega stanja (HAQ): višje vrednosti pomenijo manjšo okvaro funkcije
HAQ = Health Assessment Questionnaire; greater values indicate less disability. p = 0.030 and < 0.001 for the 3 mg/kg and 6 mg/kg treatment groups respectively vs. placebo + MTX.
HAQ = vprašalnik za oceno zdravstvenega stanja; večje vrednosti pomenijo manjšo okvaro sklepov p = 0,030 in < 0,001 za terapevtski skupini, ki sta prejemali 3 mg/kg in 6 mg/kg v primerjavi s placebom + MTX
HAQ = Health Assessment Questionnaire; greater values indicate less disability. p = 0.030 and <0.001 for the 3 mg/kg and 6 mg/kg treatment groups respectively vs. placebo + MTX.
HAQ = vprašalnik za oceno zdravstvenega stanja; večje vrednosti pomenijo manjšo okvaro sklepov p = 0,030 in < 0,001 za terapevtski skupini, ki sta prejemali 3 mg/kg in 6 mg/kg v primerjavi s placebom + MTX
HAQ change from baseline over timee (patients evaluated)
spreminjanje HAQ glede na začetno vrednost s časome (pregledani bolniki)
HAQ-DI (adjusted mean change from baseline)
HAQ-DI (prilagojena povprečna sprememba od izhodišča)
hard
kapsula
hard capsule
(alu/alu)
hard capsule
kapsula
Hard capsule (capsule)
trda kapsula (kapsula).
Hard capsule 270 capsules
trda kapsula 270 kapsul
hard capsule 6 x 1 hard capsule
trda kapsula 6 x 1 trda kapsula
Hard capsule 90 capsules.
trda kapsula 90 kapsul
Hard capsule content:
Vsebina trde kapsule:
Hard capsule of size 00 with orange opaque colour cap and body imprinted with “400 mg” in black ink.
Trda kapsula velikosti 00 s pokrovčkom neprosojne oranžne barve in telesom kapsule s črnim napisom “400 mg”.
Hard capsule with light orange cap and light orange body imprinted with 100 mg in black ink.
Trda kapsula s svetlo oranžnim pokrovčkom in svetlo oranžnim telesom kapsule s črnim napisom “100 mg”.
Hard capsule with light yellow cap and light yellow body imprinted with 50 mg in black ink.
Trda kapsula s svetlo rumenim pokrovčkom in svetlo rumenim telesom kapsule s črnim napisom “50 mg”.
Hard capsule(capsule).
trda kapsula (kapsula)
Hard capsule.
trde kapsule
Hard capsule.
Trde kapsule.
Hard capsule270 capsules
trda kapsula 270 kapsul
Hard capsules
trda kapsula
Hard capsules
Trde kapsule.
Hard capsules should not be given to children under approximately six years of age because they may not be able to swallow them and they may choke.
Do približno 6. leta starosti otrokom ne smete dajati trdih kapsul, ker jih morda ne bodo mogli pogoltniti in se lahko zadušijo.
hard capsules topotecan
trde kapsule topotekan
hard faeces
trdo blato,
Hard gastro-resistant capsule.
Trda gastrorezistentna kapsula
Hard gastro-resistant capsule.
trde gastrorezistentne kapsule
Hard gastro-resistant capsule.
Trde gastrorezistentne kapsule.
Hard gastro-resistant capsules
trda gastroreristentna kapsula
Hard gastro-resistant capsules
trda gastrorezistentna kapsula
Hard gelatine capsules Novartis Farmacéutica S.A. Ronda Santa Maria 158
Trde kapsule iz želatine Novartis Farmacéutica S.A. Ronda Santa Maria 158
hard mass, lump (nodule) at the injection site bruising at the injection site
zatrdlina, vozlič (nodul) na mestu injiciranja, modrica na mestu injiciranja.
hard stools (stools which are hard “like a rock”) incomplete emptying of the rectum (after having a bowel movement, the feeling as if a stool is still in the rectum which needs to come out)
trdo blato (blato, ki je trdo "kot kamen"), nepopolna izpraznitev danke (po iztrebljanju blata ostaja občutek, kot da je blato še vedno v danki in mora ven).
Hard transparent gelatin capsules containing a fine white powder.
Trde prozorne želatinske kapsule, ki vsebujejo droben bel prašek.
hardened skin or bumps pain, feeling sore or tender
zatrdela koža ali izbokline, bolečina, občutek razbolelosti ali občutljivost.
hardening
zatrdline
hardening of the skin fall
otrdelost kože padci
hardening of the skin which may affect also soft tissue and internal organs (nephrogenic systemic fibrosis), feeling unwell
zadebelitev kože, ki lahko vpliva tudi na mehka tviva in notranje organe (nefrogena sistemska fibroza), občutek neugodja
hardness redness, swelling or bruising at the injection site
otrdlina, rdečina, oteklina ali podplutba na mestu injiciranja,
hardness, redness or swelling at the injection site
otrdlina, rdečina ali oteklina na mestu injiciranja,
hardness, redness, swelling or bruising at the injection site
otrdlina, rdečina, oteklina ali podplutba na mestu injiciranja,
hardness, redness, swelling or bruising at the injection site abnormal, reduced sensation
otrdelost tkiva, rdečina, oteklina ali podplutba na mestu injiciranja, nenormalno čutenje.
hardness, redness, swelling or minor bleeding at the injection site abnormal, reduced sensation
otrdlina, rdečina, oteklina ali manjša krvavitev na mestu injiciranja, nenormalno oz. zmanjšano čutenje.
harmaceutical Form
Farmacevtska oblika
Harmful for those suffering from alcoholism.
Škoduje osebam z alkoholizmom.
harmless reddish-brown discolouration of urine
neškodljivo rdečkastorjavo obarvanje urina
Harmony Ibis, study with a similar design, was limited to 18 mg once a day.
Študija Harmony Ibis s podobnim načrtom je bila omejena na 18 mg enkrat na dan.
harp chest pain which may increase with deep breathing;
ostra bolečina v prsih, ki se lahko poveča med globokim dihanjem;
harp chest pain which may increase with deep breathing;
ostre bolečine v prsnem košu, ki se lahko z globokim dihanjem poslabša;
harp chest pain;
ostra bolečina v prsih,
harp chest pain;
ostra bolečina v prsih;
harsh, raspy, or strained voice; nosebleed; nasal congestion
rezek, hripav ali nenaraven glas, krvavitev iz nosu, zamašen nos
harsh, raspy, or strained voice; nosebleed; nasal congestion
rezek, hripav ali nenaraven glas, krvavitev iz nosu, zamašenost nosu
Harvoni + ribavirin for 12 weeks or Harvoni (without ribavirin) for 24 weeks should be considered for previously treated patients with uncertain subsequent retreatment options (see section 4.4).
O 12 tednih zdravila Harvoni + ribavirina ali 24 tednih zdravila Harvoni (brez ribavirina) je treba razmisliti pri predhodno zdravljenih bolnikih z negotovo možnostjo za naknadno ponovno zdravljenje (glejte poglavje 4.4).
Harvoni + ribavirin for 24 weeks (see sections 4.4 and 5.1).
Zdravilo Harvoni + ribavirin 24 tednov (glejte poglavji 4.4 in 5.1).
Harvoni 90 mg/400 mg film-coated tablets
Harvoni 90 mg/400 mg filmsko obložene tablete
Harvoni [Outer packaging only]
Harvoni [samo zunanja ovojnina]
Harvoni can only be obtained with a prescription and treatment should be started and monitored by a doctor experienced in the management of patients with chronic hepatitis C.
Izdaja zdravila Harvoni je le na recept, zdravljenje pa mora uvesti in spremljati zdravnik, ki ima izkušnje z zdravljenjem bolnikov s kroničnim hepatitisom C.
Harvoni for 8 weeks may be considered in previously untreated genotype 1-infected patients (see section 5.1, ION-3 study).
O 8 tednih zdravila Harvoni je možno razmisliti pri predhodno nezdravljenih bolnikih, okuženih z genotipom 1 (glejte poglavje 5.1, študija ION-3).
Harvoni is an antiviral medicine used to treat adults with chronic (long-term) hepatitis C (an infectious disease that affects the liver, caused by the hepatitis C virus).
Zdravilo Harvoni je protivirusno zdravilo, namenjeno zdravljenju odraslih s kroničnim (dolgotrajnim) hepatitisom C (nalezljivo boleznijo jeter, ki jo povzroča virus hepatitisa C).
Harvoni is contraindicated with rifabutin, a potent intestinal P-gp inducer (see section 4.3).
Zdravilo Harvoni je kontraindicirano z rifabutinom, ki je močan induktor P-gp v črevesju (glejte poglavje 4.3).
Harvoni is contraindicated with St. John’s wort, a potent intestinal P-gp inducer (see section 4.3).
Zdravilo Harvoni je kontraindicirano s šentjanževko, ki je močan induktor P-gp v črevesju (glejte poglavje 4.3).
Harvoni is indicated for the treatment of chronic hepatitis C (CHC) in adults (see sections 4.2, 4.4 and 5.1).
Zdravilo Harvoni je indicirano za zdravljenje kroničnega hepatitisa C (CHC-chronic hepatitis C) pri odraslih (glejte poglavja 4.2, 4.4 in 5.1).
Harvoni tablets are supplied in high density polyethylene (HDPE) bottles with a polypropylene child-resistant closure containing 28 film-coated tablets with a silica gel desiccant and polyester coil.
Tablete zdravila Harvoni so dobavljene v plastenkah iz polietilena visoke gostote (HDPE) z za otroke varno zaporko iz polipropilena, s sušilnim sredstvom iz silikagela in poliestrsko vato, ki vsebujejo
Harvoni was investigated in three main studies involving a total of around 2,000 patients infected with hepatitis C of genotype 1 who did not have failure of liver function.
Zdravilo Harvoni so proučevali v treh glavnih študijah, v katerih je skupno sodelovalo približno 2 000 bolnikov, okuženih s hepatitisom C genotipa 1, ki jim jetra niso odpovedovala.
has a bleeding disorder (a disease that makes you bleed more than normal), for example haemophilia has a weakened immune system, for example due to a genetic defect, HIV infection or medicines that affect the immune system.
motnje strjevanja krvi (bolezen, pri kateri neobičajno pogosto krvavite), na primer hemofilijo; oslabljen imunski sistem, npr. zaradi genetske okvare, okužbe z virusom HIV ali zdravil, ki vplivajo na imunski sistem.
has a bleeding disorder (a disease that makes you bleed more than normal), for example haemophilia; has a weakened immune system, for example due to a genetic defect, HIV infection or medicines that affect the immune system; suffer from an illness with high fever.
motnjo strjevanja krvi (bolezen, pri kateri krvavite več, kot je normalno), na primer hemofilijo, oslabljen imunski sistem, na primer zaradi genetske okvare, okužbe z virusom HIV ali zdravil, ki vplivajo na imunski sistem, bolezen z močno zvišano telesno temperaturo.
has a close contact such as a household member who has a weakened immune system, e.g., a person with cancer or who is taking medicines that may weaken the immune system.
če je vaš otrok v tesnem stiku z osebo (npr. v skupnem gospodinjstvu), ki ima oslabljen imunski sistem, npr. z osebo z rakom ali z osebo, ki se zdravi z zdravili, ki lahko oslabijo imunski sistem.
has a heart condition, such as changes to the rhythm or rate of heart beat, or heart disease;
če imate vi ali vaš otrok stanja srca, kot so spremembe srčnega ritma ali hitrost utripa ali srčno bolezen;
has a heart problem (such as disorders of the heart rhythm and heart failure.
rčne težave (npr. motnje srčnega ritma in srčno popuščanje).
has a severe type of malaria infection which has affected parts of the body such as the brain, lungs or kidneys;
če imate vi ali vaš otrok hudo vrsto okužbe z malarijo, ki je prizadela dele telesa, kot so možgani, pljuča ali ledvice;
Has an allergy to the active substance (fentanyl) or to any of the excipients.
Ima alergijo na zdravilno učinkovino (fentanil) ali katero od pomožnih snovi.
has an anaemia or low neutrophil count, has an allergic reaction to masitinib, the active ingredient of Masivet or an excipient used in this medicine.
ima anemijo ali nizko število nevtrofilcev, ima alergijsko reakcijo na masitinib, zdravilno učinkovino zdravila Masivet, ali na pomožne snovi, uporabljene v tem zdravilu.
has an obstruction of the stomach (pyloric stenosis) or bowel causing vomiting
v primeru zapore želodca (pilorična stenoza) ali črevesja, ki povzroča bruhanje,
has answered any questions you may have. if you are pregnant or intend to become pregnant.
Zdravniku morate povedati, če ste noseči ali nameravate zanositi.
has any disorder of the gastrointestinal system. has not been gaining weight and growing as expected.
če ima vaš otrok kakršno koli bolezen prebavil. če sta otrokovo pridobivanje na telesni masi in njegova rast počasnejša, kot je pričakovano.
has asthma or history of breathing difficulties. has a slow heart rate for his/her age.
astmo ali je imel v preteklosti težave z dihanjem. počasen srčni utrip za svojo starost.
Has broken, damaged or diseased skin at the treatment site.
Ima raztrgano, poškodovano ali bolno kožo na mestu zdravljenja.
has cardiac or hepatic disease
z boleznimi srca ali jeter
has chronic liver diseases known to represent preneoplastic conditions (e.g. advanced liver fibrosis, cirrhosis, viral hepatitis, neonatal liver disease or congenital enzyme defects)
ima bolnik kronično bolezen jeter, za katero je znano, da predstavlja preneoplastično stanje (npr. napredovalo jetrno fibrozo, cirozo, virusni hepatitis, neonatalno jetrno bolezen ali prirojeni encimski defekt)
has circulation problems which make the toes and fingers numb and pale.
težave s krvnim obtokom, zaradi katerih postanejo prsti na nogah in rokah otrpli in bledi.
has diarrhoea (frequent, loose watery stools)
v primeru driske (pogosto odvajanje tekočega vodenega blata),
has explained the measures necessary to minimise those risks,
ne opiše ukrepov, potrebnih za zmanjšanje teh tveganj na najnižjo možno raven, odgovori na vprašanja, ki jih morda imate.
has glaucoma (raised pressure in the eye)
če ima glavkom (zvišan tlak v očesu),
has had an allergic reaction
imel alergično reakcijo:
has had any of the following events after receiving a pertussis vaccine, as the decision to give further doses of pertussis containing vaccine will need to be carefully considered: fever of 40°C or above within 48 hours not due to another identifiable cause.
imel po prejemu cepiva proti oslovskemu kašlju katerega koli izmed naslednjih neželenih učinkov, je treba temeljito pretehtati odločitev o dajanju nadaljnjih odmerkov cepiva: temperatura 40 °C ali več v 48 urah, ki ni bila posledica drugega ugotovljenega vzroka;
has had any of the following events after receiving a vaccine against pertussis (whooping cough), as the decision to give further doses of pertussis containing vaccine will need to be carefully considered: had a fever of 40.5°C or above within 48 hours not due to another identifiable cause.
po prejemu cepiva proti oslovskemu kašlju imel katerega koli izmed naslednjih neželenih učinkov, saj je treba temeljito pretehtati odločitev o dajanju nadaljnjih odmerkov cepiva, ki vsebuje oslovski kašelj: vročino 40,5 °C ali več v 48 urah, ki ni bila posledica drugega ugotovljenega vzroka,
has had gastrointestinal ulceration or bleeding
z želodčnimi ali črevesnimi razjedami ali s krvavitvijo
has had respiratory disorder or swelling of the face (anaphylactic reaction) after administration of Hexacima
imel motnje dihanja ali otekanje obraza (anafilaktično reakcijo) po cepljenju s cepivom Hexacima.
has had respiratory disorder or swelling of the face (anaphylactic reaction) after administration of Hexacima.
imel motnje dihanja ali otekanje obraza (anafilaktično reakcijo) po cepljenju s cepivom Hexacima.
has had respiratory disorder or swelling of the face (anaphylactic reaction) after administration of Hexyon
imel motnje dihanja ali otekanje obraza (anafilaktično reakcijo) po cepljenju s cepivom Hexyon.
has had respiratory disorder or swelling of the face (anaphylactic reaction) after administration of Hexyon.
imel motnje dihanja ali otekanje obraza (anafilaktično reakcijo) po cepljenju s cepivom Hexyon.
has had shortness of breath or swelling of the face (anaphylactic reaction) after administration of a previous dose of Vaxelis.
imel težave z dihanjem ali otekanje obraza (anafilaktično reakcijo) po predhodnem odmerku cepiva Vaxelis;
Has heart failure, low or high blood pressure, low blood volume, impaired breathing, has a history of epilepsy, non-aged related corneal pathology or has or might have a partial or completely stationary bowel.
Ima srčno napako, nizek ali visok krvni tlak, nizek volumen krvi, prizadeto dihanje, ima epilepsijo v preteklosti, kornealno patologijo, ki ni v zvezi s staranjem ali ima ali bi utegnil imeti delno ali popolnoma stacionarno črevesje.
has liver or kidney problems; has a malaria infection caused by a parasite other than Plasmodium falciparum;
imate vi ali vaš otrok težave z jetri ali ledvicami; imate vi ali vaš otrok okužbo z malarijo, ki jo povzroča drug parazit, ne Plasmodium falciparum;
has liver or kidney problems; has a malaria infection caused by a parasite other than Plasmodium falciparum;
imate vi ali vaš otrok težave z jetri ali ledvicami; imate vi ali vaš otrok okužbo z malarijo, ki jo povzroča drugi parazit, ne Plasmodium falciparum;
has menstruated at any time during the previous 12 consecutive months,
je imela menstruacijo kadarkoli v zadnjih 12 zaporednih mesecih,
has menstruated at any time during the previous 12 consecutive months,
je imela menstruacijo kadarkoli v zadnjih zaporednih 12 mesecih,
has myasthenia gravis (muscle weakness and tiredness) is taking any of the following medicines (see section Other medicines and Sialanar): potassium chloride solid oral dose; anticholinergic medicines.
v primeru miastenije gravis (mišična šibkost in utrujenost), če jemlje katero koli od naslednjih zdravil (glejte poglavje Druga zdravila in zdravilo Sialanar): peroralni odmerek kalijevega klorida v obliki trde farmacevtske oblike, antiholinergiki.
has not been directly
neposredno ovrednoten.
has not been established,
niso dognali, priporočamo
has not undergone a hysterectomy or a bilateral oophorectomy, or who does not have medically-confirmed permanent premature ovarian failure, does not have a XY genotype, Turner’s syndrome or uterine agenesis, becomes amenorrhoeic following cancer therapy, including treatment with Odomzo.
ji niso odstranili maternice ali obeh jajčnikov in nima medicinsko potrjene prezgodnje trajne odpovedi jajčnikov, nima genotipa XY, Turnerjevega sidroma ali agenezije maternice, je izgubila menstruacijo po zdravljenju raka, kar lahko vključuje zdravljenje z zdravilom Odomzo.
has not undergone a hysterectomy or a bilateral oophorectomy, or who does not have medically-confirmed permanent premature ovarian failure, does not have a XY genotype, Turner’s syndrome, or uterine agenesis, becomes amenorrhoeic following cancer therapy, including treatment with Erivedge.
ni opravila histerektomije ali obojestranske ooforektomije ter nima medicinsko potrjene trajne prezgodnje odpovedi jajčnikov, nima genotipa XY, Turnerjevega sindroma ali agenezije maternice, ima po zdravljenju raka, vključno z zdravilom Erivedge, amenorejo.
has received a blood transfusion or immunoglobulins within the last 6 weeks.
če je vaš otrok v zadnjih 6 tednih prejel transfuzijo krvi ali imunoglobuline.
has severe kidney disease
v primeru hudega obolenja ledvic,
has severe liver function impairment
ima bolnik hude motnje v delovanju jeter
has severe liver, kidney or heart disease.
ima hudo bolezen jeter, ledvic ali srca;
has spread to other parts of the body (called “metastatic” basal cell carcinoma) has spread to areas nearby (called “locally advanced” basal cell carcinoma) and your doctor decides that treatment with surgery or radiation is inappropriate.
razširil v druge dele telesa (takšen rak imenujemo "metastatski" bazalnocelični karcinom), razširil v okoliške predele (takšen rak imenujemo "lokalno napredovali" bazalnocelični karcinom), zdravnik pa presodi, da zdravljenje z operacijo ali obsevanjem ni primerno.
has suffered from a severe reaction affecting the brain (encephalopathy) within 7 days of a prior dose of a pertussis vaccine (acellular or whole cell pertussis). has an uncontrolled condition or severe illness affecting the brain and nervous system (uncontrolled neurologic disorder) or uncontrolled epilepsy.
imel hudo reakcijo na možganih (encefalopatija) v 7 dneh po predhodnem odmerku cepiva proti oslovskemu kašlju (brezceličen ali s celimi celicami); ima nenadzorovano stanje ali hudo bolezen, ki prizadene možgane in živčevje (nenadzorovano nevrološko bolezen), ali nenadzorovano epilepsijo.
has ulcerative colitis (inflammation of the intestine)
v primeru ulceroznega kolitisa (vnetje črevesja),
has very low blood pressure.
zelo nizek krvni tlak.
Haselünne/IDT2617/2003(H1N1) ≥ 10.22 log2 GMNU* Bakum/1832/2000 (H1N2) ≥ 12.34 log2 GMNU*
Haselünne/IDT2617/2003 (H1N1) ≥ 10.22 log2 GMNU, Bakum/1832/2000 (H1N2) ≥ 12.34 log2 GMNU,
Haselünne/IDT2617/2003(H1N1) ≥ 10.22 log2 GMNU, Bakum/1832/2000 (H1N2) ≥ 12.34 log2 GMNU
Haselünne/IDT2617/2003 (H1N1) ≥ 10.22 log2 GMNU, Bakum/1832/2000 (H1N2) ≥ 12.34 log2 GMNU,
Hatfield, Hertfordshire AL10 9SN, United Kingdom
Hatfield, Hertfordshire, AL10 9SN, Velika Britanija
Hatfield, Hertfordshire, AL10 9SN, United Kingdom
Hatfield, Hertfordshire, AL10 9SN, Velika Britanija
Hatfield, Herts AL10 9SN United Kingdom
Hatfield, Herts AL10 9SN Velika Britanija
have a basal antral follicle count (the number of small follicles present in your ovaries at the beginning of a menstrual cycle) higher than 20
če imate bazalno število antralnih foliklov (število majhnih foliklov, ki so navzoči v jajčnikih ob začetku menstrualnega ciklusa) večje od 20.
have a bodyweight of less than 60 kg are over 75 years of age
če imate telesno maso manjšo od 60 kg, če ste starejši od 75 let.
have a condition called ‘autoimmune hepatitis’ are taking bepridil, pimozide, oral midazolam, oral triazolam, simvastatin, lovastatin, alfuzosin, silodosin, 'ergot’ type medicines (such as dihydro-ergotamine, ergonovine, ergotamine or methylergonovine), lumefantrine, halofantrine, quetiapine, or tyrosine kinase inhibitors.
če imate bolezen, imenovano "avtoimunski hepatitis", če jemljete bepridil, pimozid, peroralni midazolam, peroralni triazolam, simvastatin, lovastatin, alfuzosin, silodozin, zdravila ergotskega tipa (npr. dihidroergotamin, ergonovin, ergotamin ali metilergonovin), lumefantrin, halofantrin, kvetiapin ali zaviralce tirozin-kinaze.
have a condition that may be associated with dehydration (large loss of body fluids) such as being sick with severe vomiting, diarrhoea or fever, or if you drink fluids a lot less than normal
če imate bolezen, ki bi lahko bila povezana z dehidracijo (veliko izgubo telesnih tekočin), kot so slabost s hudim bruhanjem, driska ali zvišana telesna temperatura, ali če pijete manj tekočin, kot je normalno.
have a condition that may be associated with dehydration (large loss of body fluids) such as being sick with severe vomiting, diarrhoea or fever, or if you drink fluids a lot less than normal.
pride do stanja, ki lahko povzroči dehidracijo (veliko izgubo telesnih tekočin), na primer zaradi hudega bruhanja, driske ali vročine ali, če popijete veliko manj tekočin kot običajno;
have a disease due to a blocked or narrow vein in the lungs rather than a blocked or narrow artery.
imate bolezen zaradi zamašene ali zožene vene v pljučih, ne pa zaradi zamašene ali zožene arterije.
have a disease of the adrenal gland called primary hyperaldosteronism
imate bolezen nadledvičnih žlez, ki se imenuje primarni hiperaldosteronizem,
have a disease of the adrenal gland called primary hyperaldosteronism.
imate bolezen nadledvičnih žlez, ki se imenuje primarni hiperaldosteronizem,
have a dry mouth
uha usta,
have a head injury or brain tumour;
imate poškodbo glave ali možganski tumor;
have a high body mass index
imate visok indeks telesne mase
have a high level of calcium in your urine;
imate visoko raven kalcija v urinu,
have a history of bleeding disorders (tendency to develop bruises)
te v preteklosti imeli motnje strjevanja krvi (nagnjenost k razvoju podplutb)
have a history of bleeding disorders (tendency to develop bruises);
te v preteklosti imeli motnje strjevanja krvi (nagnjenost k razvoju podplutb);
have a history of eye problems as you may need extra monitoring of your eyes have a severe skin reaction.
te v preteklosti imeli bolezni oči, ker boste morda potrebovali dodatne kontrole oči imate hudo kožno reakcijo.